Soleus Capital Management, L.P. Y M Abs Therapeutics, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.21 Billion
- Q1 2025
A detailed history of Soleus Capital Management, L.P. transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 349,982 shares of YMAB stock, worth $1.64 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
349,982
Previous 349,982
-0.0%
Holding current value
$1.64 Million
Previous $2.74 Million
43.43%
% of portfolio
0.13%
Previous 0.19%
Shares
11 transactions
Others Institutions Holding YMAB
# of Institutions
105Shares Held
27.1MCall Options Held
38.4KPut Options Held
2.1K-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$19.9 Million0.96% of portfolio
-
Acorn Capital Advisors, LLC New York, NY3.24MShares$15.2 Million9.97% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$13.8 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$10.3 Million0.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$9.15 Million0.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $205M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...